Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.

International journal of clinical and experimental medicine

Miles FL, Rao JY, Eckhert C, Chang SC, Pantuck A, Zhang ZF.
PMID: 26379965
Int J Clin Exp Med. 2015 Jun 24;8(7):11470-6. eCollection 2015.

The progression of prostate cancer is influenced by systemic inflammation, and may be attributed, in part, to genetic predisposition. Single nucleotide polymorphisms associated with the immune response may help mediate prostate cancer progression. We analyzed data from a hospital-based...

Cite
Miles FL, Rao JY, Eckhert C, et al. Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients. Int J Clin Exp Med. 2015;8(7):11470-6
Miles, F. L., Rao, J. Y., Eckhert, C., Chang, S. C., Pantuck, A., & Zhang, Z. F. (2015). Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients. International journal of clinical and experimental medicine, 8(7), 11470-6.
Miles, Fayth L, et al. "Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients." International journal of clinical and experimental medicine vol. 8,7 (2015): 11470-6.
Miles FL, Rao JY, Eckhert C, Chang SC, Pantuck A, Zhang ZF. Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients. Int J Clin Exp Med. 2015 Jun 24;8(7):11470-6. eCollection 2015. PMID: 26379965; PMCID: PMC4565348.
Copy Download .nbib Format: NLM
Urachal adenocarcinoma.

The Canadian journal of urology

Pantuck AJ, Vates TS, Javidian P, Weiss RE.
PMID: 12735811
Can J Urol. 1997 Dec;4(4):450-452.

Primary adenocarcinoma of the bladder is a rare neoplasm comprising less than 2% of all bladder tumors. Approximately one-third of primary bladder adenocarcinoma arise in the urachal remnant. Differentiation from vesical adenocarcinoma preoperatively is essential because the surgical approach...

Cite
Pantuck AJ, Vates TS, Javidian P, et al. Urachal adenocarcinoma. Can J Urol. 1997;4(4):450-452
Pantuck, A. J., Vates, T. S., Javidian, P., & Weiss, R. E. (1997). Urachal adenocarcinoma. The Canadian journal of urology, 4(4), 450-452.
Pantuck, A. J., et al. "Urachal adenocarcinoma." The Canadian journal of urology vol. 4,4 (1997): 450-452.
Pantuck AJ, Vates TS, Javidian P, Weiss RE. Urachal adenocarcinoma. Can J Urol. 1997 Dec;4(4):450-452. PMID: 12735811.
Copy Download .nbib Format: NLM
Genital hair strangulation in an uncircumcised boy.

The Canadian journal of urology

Pantuck AJ, Fleisher MH, Barone JG.
PMID: 12735813
Can J Urol. 1997 Dec;4(4):455.

Penile strangulation injury due to a coil of hair acting as a tourniquet is an uncommon injury in boys that has severe potential complications if diagnosis is delayed. We report the first such case in an uncircumcised boy. The...

Cite
Pantuck AJ, Fleisher MH, Barone JG. Genital hair strangulation in an uncircumcised boy. Can J Urol. 1997;4(4):455
Pantuck, A. J., Fleisher, M. H., & Barone, J. G. (1997). Genital hair strangulation in an uncircumcised boy. The Canadian journal of urology, 4(4), 455.
Pantuck, Allan J., et al. "Genital hair strangulation in an uncircumcised boy." The Canadian journal of urology vol. 4,4 (1997): 455.
Pantuck AJ, Fleisher MH, Barone JG. Genital hair strangulation in an uncircumcised boy. Can J Urol. 1997 Dec;4(4):455. PMID: 12735813.
Copy Download .nbib Format: NLM
Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover.

Science (New York, N.Y.)

Kantack EJ, Martin WJ, Newsom LD.
PMID: 17781179
Science. 1958 Jun 20;127(3312):1448. doi: 10.1126/science.127.3312.1448.

No abstract available.

Cite
Kantack EJ, Martin WJ, Newsom LD. Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover. Science. 1958;127(3312):1448doi: 10.1126/science.127.3312.1448.
Kantack, E. J., Martin, W. J., & Newsom, L. D. (1958). Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover. Science (New York, N.Y.), 127(3312), 1448. https://doi.org/10.1126/science.127.3312.1448
Kantack, E J, et al. "Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover." Science (New York, N.Y.) vol. 127,3312 (1958): 1448. doi: https://doi.org/10.1126/science.127.3312.1448
Kantack EJ, Martin WJ, Newsom LD. Transmission of Internal Cork of Sweet Potato by the Cotton Aphid, Aphis gossypii Glover. Science. 1958 Jun 20;127(3312):1448. doi: 10.1126/science.127.3312.1448. PMID: 17781179.
Copy Download .nbib Format: NLM
Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association.

Reviews in urology

Zisman A, Pantuck AJ, Freedland SJ, Belldegrun AS.
PMID: 16985697
Rev Urol. 2001;3(2):99-101.

No abstract available.

Cite
Zisman A, Pantuck AJ, Freedland SJ, et al. Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association. Rev Urol. 2001;3(2):99-101
Zisman, A., Pantuck, A. J., Freedland, S. J., & Belldegrun, A. S. (2001). Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association. Reviews in urology, 3(2), 99-101.
Zisman, A, et al. "Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association." Reviews in urology vol. 3,2 (2001): 99-101.
Zisman A, Pantuck AJ, Freedland SJ, Belldegrun AS. Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association. Rev Urol. 2001;3(2):99-101. PMID: 16985697; PMCID: PMC1476044.
Copy Download .nbib Format: NLM
Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Reviews in urology

Perry K, Zisman A, Pantuck AJ, Janzen N, Schulam P, Belldegrun AS.
PMID: 16985666
Rev Urol. 2002;4(3):103-11.

Widespread use of computed tomography, ultrasound, and magnetic resonance imaging has led to an increase in detection of relatively small renal masses, and approaches to managing them have evolved in the last two decades. Indications for nephron-sparing surgery have...

Cite
Perry K, Zisman A, Pantuck AJ, et al. Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. Rev Urol. 2002;4(3):103-11
Perry, K., Zisman, A., Pantuck, A. J., Janzen, N., Schulam, P., & Belldegrun, A. S. (2002). Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. Reviews in urology, 4(3), 103-11.
Perry, Kent, et al. "Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma." Reviews in urology vol. 4,3 (2002): 103-11.
Perry K, Zisman A, Pantuck AJ, Janzen N, Schulam P, Belldegrun AS. Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. Rev Urol. 2002;4(3):103-11. PMID: 16985666; PMCID: PMC1475990.
Copy Download .nbib Format: NLM
Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas.

Reviews in urology

Pantuck A, Zisman A, Belldegrun A.
PMID: 16985727
Rev Urol. 2000;2(1):22-4.

No abstract available.

Cite
Pantuck A, Zisman A, Belldegrun A. Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas. Rev Urol. 2000;2(1):22-4
Pantuck, A., Zisman, A., & Belldegrun, A. (2000). Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas. Reviews in urology, 2(1), 22-4.
Pantuck, A, et al. "Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas." Reviews in urology vol. 2,1 (2000): 22-4.
Pantuck A, Zisman A, Belldegrun A. Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas. Rev Urol. 2000;2(1):22-4. PMID: 16985727; PMCID: PMC1476093.
Copy Download .nbib Format: NLM
Systemic therapy for metastatic renal cell carcinoma: a review and update.

Reviews in urology

Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, Slamon DJ, Kabbinavar FF.
PMID: 23526579
Rev Urol. 2012;14(3):65-78.

An in-depth understanding of metastatic renal cell carcinoma (mRCC) is important so that practitioners can make informed evidenced-based decisions with patients to optimize not only quantity of life but quality of life as well. Therefore, this review focuses on...

Cite
Logan JE, Rampersaud EN, Sonn GA, et al. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012;14(3):65-78
Logan, J. E., Rampersaud, E. N., Sonn, G. A., Chamie, K., Belldegrun, A. S., Pantuck, A. J., Slamon, D. J., & Kabbinavar, F. F. (2012). Systemic therapy for metastatic renal cell carcinoma: a review and update. Reviews in urology, 14(3), 65-78.
Logan, Joshua E, et al. "Systemic therapy for metastatic renal cell carcinoma: a review and update." Reviews in urology vol. 14,3 (2012): 65-78.
Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, Slamon DJ, Kabbinavar FF. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012;14(3):65-78. PMID: 23526579; PMCID: PMC3602729.
Copy Download .nbib Format: NLM
Reply by Authors.

The Journal of urology

Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S.
PMID: 33355501
J Urol. 2021 Mar;205(3):779. doi: 10.1097/JU.0000000000001362.03. Epub 2020 Dec 23.

No abstract available.

Cite
Klotz L, Pavlovich CP, Chin J, et al. Reply by Authors. J Urol. 2020;205(3):779doi: 10.1097/JU.0000000000001362.03.
Klotz, L., Pavlovich, C. P., Chin, J., Hatiboglu, G., Koch, M., Penson, D., Raman, S., Oto, A., Fütterer, J., Serrallach, M., Relle, J., Lotan, Y., Heidenreich, A., Bonekamp, D., Haider, M., Tirkes, T., Arora, S., Macura, K. J., Costa, D. N., Persigehl, T., Pantuck, A. J., Bomers, J., Burtnyk, M., Staruch, R., & Eggener, S. (2021). Reply by Authors. The Journal of urology, 205(3), 779. https://doi.org/10.1097/JU.0000000000001362.03
Klotz, Laurence, et al. "Reply by Authors." The Journal of urology vol. 205,3 (2021): 779. doi: https://doi.org/10.1097/JU.0000000000001362.03
Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S. Reply by Authors. J Urol. 2021 Mar;205(3):779. doi: 10.1097/JU.0000000000001362.03. Epub 2020 Dec 23. PMID: 33355501.
Copy Download .nbib Format: NLM
Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model.

Prostate cancer and prostatic diseases

Pantuck AJ, Zismon A, Tso CL, Belldegrun AS.
PMID: 12497078
Prostate Cancer Prostatic Dis. 2000 Dec;3(4):280-282. doi: 10.1038/sj.pcan.4500473.

In most clinical trials of intermittent androgen deprivation (IAD), the decision to stop androgen withdrawal is based on monitoring PSA levels, waiting for its drop to nadir. Based on in vitro pre-clinical studies, a modified 'on-off' schedule of short...

Cite
Pantuck AJ, Zismon A, Tso CL, et al. Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model. Prostate Cancer Prostatic Dis. 2000;3(4):280-282doi: 10.1038/sj.pcan.4500473.
Pantuck, A. J., Zismon, A., Tso, C. L., & Belldegrun, A. S. (2000). Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model. Prostate cancer and prostatic diseases, 3(4), 280-282. https://doi.org/10.1038/sj.pcan.4500473
Pantuck, A J, et al. "Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model." Prostate cancer and prostatic diseases vol. 3,4 (2000): 280-282. doi: https://doi.org/10.1038/sj.pcan.4500473
Pantuck AJ, Zismon A, Tso CL, Belldegrun AS. Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model. Prostate Cancer Prostatic Dis. 2000 Dec;3(4):280-282. doi: 10.1038/sj.pcan.4500473. PMID: 12497078.
Copy Download .nbib Format: NLM
Optimizing peptide epitope-based autoantibody detection in cancer patients.

American journal of clinical and experimental immunology

Wang M, Lomeli SH, Franklin WA, Lee S, Pantuck AJ, Zeng G.
PMID: 29181273
Am J Clin Exp Immunol. 2017 Nov 01;6(5):84-91. eCollection 2017.

Autoantibody (autoAb) response is an important arm of endogenously arising anti-tumor immune responses, and has received new attention as a cancer biomarker with the recent success of immune check-point inhibitor therapy. Our laboratory has been focusing on measuring autoAb...

Cite
Wang M, Lomeli SH, Franklin WA, et al. Optimizing peptide epitope-based autoantibody detection in cancer patients. Am J Clin Exp Immunol. 2017;6(5):84-91
Wang, M., Lomeli, S. H., Franklin, W. A., Lee, S., Pantuck, A. J., & Zeng, G. (2017). Optimizing peptide epitope-based autoantibody detection in cancer patients. American journal of clinical and experimental immunology, 6(5), 84-91.
Wang, Maize, et al. "Optimizing peptide epitope-based autoantibody detection in cancer patients." American journal of clinical and experimental immunology vol. 6,5 (2017): 84-91.
Wang M, Lomeli SH, Franklin WA, Lee S, Pantuck AJ, Zeng G. Optimizing peptide epitope-based autoantibody detection in cancer patients. Am J Clin Exp Immunol. 2017 Nov 01;6(5):84-91. eCollection 2017. PMID: 29181273; PMCID: PMC5698562.
Copy Download .nbib Format: NLM
Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al.

European urology

Finley DS, Pouliot F, Pantuck A.
PMID: 20845530
Eur Urol. 2010 Sep;58(3):466. doi: 10.1016/j.eururo.2010.06.020.

No abstract available.

Cite
Finley DS, Pouliot F, Pantuck A. Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al. Eur Urol. 2010;58(3):466doi: 10.1016/j.eururo.2010.06.020.
Finley, D. S., Pouliot, F., & Pantuck, A. (2010). Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al. European urology, 58(3), 466. https://doi.org/10.1016/j.eururo.2010.06.020
Finley, David S, et al. "Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al." European urology vol. 58,3 (2010): 466. doi: https://doi.org/10.1016/j.eururo.2010.06.020
Finley DS, Pouliot F, Pantuck A. Words of wisdom. Re: Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. Kantoff PW, Schuetz TJ, Blumenstein BA, et al. Eur Urol. 2010 Sep;58(3):466. doi: 10.1016/j.eururo.2010.06.020. PMID: 20845530.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries